discontinued

DDX1305B-50 HIV-1 gp41 antibody

See related secondary antibodies

Search for all "HIV-1"

Quick Overview

Mouse anti HIV-1 417D3.08

DDX1305B-50

More Views

  • DDX1305B-50

Product Description for HIV-1

Mouse anti HIV-1 417D3.08.
Properties: gp41
Presentation: Biotin
Product is tested for Enzyme Immunoassay, Flow Cytometry, Immunocytochemistry/Immunofluorescence, Neutralisation.

Properties for HIV-1

Product Category Primary Antibodies
Quantity 50 µg
Synonyms HIV-I, HIV1, Human immunodeficiency virus type 1
Presentation Biotin
Applications E, F, ICC/IF, NEUT
Clonality Monoclonal
Clone 417D3.08
Host Mouse
Isotype IgG1
Shipping to Germany, USA/Canada
PDF datasheet View Datasheet
Manufacturer Dendritics SAS

Datasheet Extract

Immunogen
Immunogen:
HR1-PID-HR2-transfected HEK 293 cells (HIV-1, 92BR025, Clade C).
Property gp41
Application DDX1305P-50 / DDX1305P-100 Purified: Blocking of HR1/HR2 complex formation, Cell-coated ELISA, FACS surface, ImmunoFluorescence, Neutralization, Inhibition. 
DDX1305A488-50 / DDX1305A488-100 Alexa- fluor®A488 (on request): Blocking of HR1/HR2 complex formation, Cell-coated ELISA, FACS surface, ImmunoFluorescence, Neutralization, Inhibition.
DDX1305A546-50 / DDX1305A546-100 Alexa- fluor®546 (on request): Blocking of HR1/HR2 complex formation, Cell-coated ELISA, FACS surface, ImmunoFluorescence, Neutralization, Inhibition.
DDX1305A647-50 / DDX1305A647-100 Alexa- fluor®647 (on request): Blocking of HR1/HR2 complex formation, Cell-coated ELISA, FACS surface, ImmunoFluorescence, Neutralization, Inhibition.
DDX1305B-50 / DDX1305B-100 Biotin (on request): Blocking of HR1/HR2 complex formation, Cell-coated ELISA, FACS surface, ImmunoFluorescence, Neutralization, Inhibition. 

Applications tested: Dawood R et al, AIDS. 27(5):717-730, 2013.
Usage recommendation:

*This monoclonal antibody may be used between 5-25 μg/ml.
*Optimal dilution should be determined by each laboratory for each application.
*Coupled antibody: to maintain RT before using.
Background HIV-1-gp41 is a subunit of the envelope protein complex of HIV. HIV-1-gp41 is responsible for the fusion between the viral and the cell membranes and thus represents a target for HIV vaccines. Trimeric Env is composed of gp120, which is non-covalently associated with the membrane-anchored fusion protein gp41. HIV-1 gp120 binding to CD4 and co-receptor (CCR5 or CXCR4) induces conformational changes, resulting in gp41 exposure and in the production of fusion-intermediate conformation of gp41 (HR1 and HR2). 3 neutralizing anti-gp41 monoclonal antibodies were selected from mice immunized with 293T cells stably transfected with a construct expressing HR1 plus HR2. (Dawood R et al, AIDS. 27(5):717-730, 2013)
Concentration 0.5 mg/ml
Product Citations
Originator or purchased from resellers:
  1. Dawood R, Benjelloun F, Pin JJ, Kone A, Chanut B, Jospin F, et al. Generation of HIV-1 potent and broad neutralizing antibodies by immunization with postfusion HR1/HR2 complex. AIDS. 2013 Mar 13;27(5):717-30. doi: 10.1097/QAD.0b013e32835cfca5. PubMed PMID: 23719346.
Storage -20°C. KEEP CONTENTS STERILE: no preservative.
Purified antibodies: avoid repeated freeze/thaw cycles.
Coupled antibodies: glycerol protects from freezing.
Format
Label:
Biotin
Purification:
QMA Hyper D ion exchange chromatography
Buffer System:
Purified: 100 μg in 200μl / 50 μg in 100 μl Tris-NaCl pH 8.
Coupled: 100 μg in 200μl / 50 μg in 100 μl Tris PBS 50% glycerol.
Specificity
Specificity:
Conformational epitope formed by aa 531-560 (HR1) and 623-661 (HR2).
Clone 417D3.08 referred to as clone 2 in the article.

Accessory Products

  • LinkedIn